Medspa and Dermatology Biologics Supply in Scranton, PA

Vendor qualification in aesthetic practices

Dermatology practices, plastic surgery practices, and medspas typically qualify a biologics supplier the same way they qualify any clinical-grade vendor: confirming registration and licensure documentation can be produced on request, reviewing a certificate of analysis and donor eligibility summary for a specific lot, and verifying that ordering access requires a real NPI rather than an open checkout. Because exosome products are not FDA-approved and are generally handled as biologic drugs, most practices route that documentation review through their medical director before any purchase decision.

Medical director and physician-supervision requirements

Medspas operating under physician supervision generally need their medical director's sign-off before adding a new biologics line, since account verification at Precision Biologics confirms an NPI number but does not substitute for the practice's internal physician-supervision requirements. Confirming standing with the Pennsylvania State Board of Medicine and reviewing the purchase with counsel is a separate step the practice should take on its own.

Shipping and storage for cryopreserved and lyophilized formats

Cryopreserved Wharton's jelly vials ship overnight on dry ice and move into -80 degree C storage on arrival; lyophilized exosome products are shelf-stable and stored per the insert included with the lot. A practice should assign someone to receive cryopreserved shipments promptly and to record each lot number against the patient file.

Account setup and documentation access

Setting up an account starts with NPI verification. Once verified, a practice can request full ingredient disclosure for lyophilized exosome products, characterization data, and lot-specific documentation, and can schedule a physician-level call focused on that documentation rather than on clinical recommendations.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.